Post Market Clinical Follow-Up Study of Excia T® Hip Prosthesis

Launched by AESCULAP AG · Jul 10, 2014

Keywords

ClinConnect Summary

The Post Market Clinical Follow-Up Study of the Excia T® Hip Prosthesis is looking at how well this hip implant works over ten years for people with hip arthritis. The study is currently active but not accepting new participants. It aims to gather valuable information about the performance of the Excia T® Hip Stem, which is a type of artificial hip joint used to help relieve pain and improve mobility for those suffering from hip arthritis.

To be eligible for this study, participants must be at least 18 years old and provide written consent to take part. However, pregnant individuals are not allowed to participate. Those who join the study can expect regular check-ups to monitor their hip function and overall health over the ten-year period. This information will help doctors understand how effective the Excia T® Hip Prosthesis is in the long term, ultimately aiding in improving treatment options for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient gave written informed consent
• • age ≥ 18 years
• Exclusion Criteria:
• • pregnancy